New York State Common Retirement Fund’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $168K | Hold |
|
|||||
|
2025
Q2 | $142K | Buy |
|
|||||
|
2025
Q1 | $29.7K | Sell |
|
|||||
|
2024
Q4 | $163K | Hold |
|
|||||
|
2024
Q3 | $599K | Sell |
|
|||||
|
2024
Q2 | $577K | Sell |
|
|||||
|
2024
Q1 | $1.13M | Buy |
|
|||||
|
2023
Q4 | $409K | Sell |
|
|||||
|
2023
Q3 | $330K | Buy |
|
|||||
|
2023
Q2 | $412K | Buy |
|
|||||
|
2023
Q1 | $430K | Sell |
|
|||||
|
2022
Q4 | $627K | Buy |
|
|||||
|
2022
Q3 | $472K | Buy |
|
|||||
|
2022
Q2 | $304K | Sell |
|
|||||
|
2022
Q1 | $600K | Buy |
|
|||||
|
2021
Q4 | $645K | Sell |
|
|||||
|
2021
Q3 | $437K | Sell |
|
|||||
|
2021
Q2 | $607K | Buy |
|
|||||
|
2021
Q1 | $732K | Buy |
|
|||||
|
2020
Q4 | $783K | Buy |
|
|||||
|
2020
Q3 | $247K | Hold |
|
|||||
|
2020
Q2 | $240K | Buy |
|